 Clinical Trials as Topic
"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
| Descriptor ID |
D002986
|
| MeSH Number(s) |
E05.318.760.535 E05.337.250 N05.715.360.775.235 N06.850.520.450.535
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 6 | 6 | | 1981 | 1 | 4 | 5 | | 1982 | 0 | 9 | 9 | | 1983 | 0 | 9 | 9 | | 1984 | 0 | 9 | 9 | | 1985 | 0 | 11 | 11 | | 1986 | 1 | 8 | 9 | | 1987 | 0 | 15 | 15 | | 1988 | 0 | 14 | 14 | | 1989 | 0 | 11 | 11 | | 1990 | 0 | 6 | 6 | | 1991 | 0 | 2 | 2 | | 1992 | 4 | 4 | 8 | | 1993 | 1 | 3 | 4 | | 1994 | 2 | 4 | 6 | | 1995 | 4 | 10 | 14 | | 1996 | 3 | 9 | 12 | | 1997 | 1 | 13 | 14 | | 1998 | 0 | 7 | 7 | | 1999 | 4 | 8 | 12 | | 2000 | 4 | 21 | 25 | | 2001 | 6 | 14 | 20 | | 2002 | 5 | 24 | 29 | | 2003 | 8 | 22 | 30 | | 2004 | 10 | 45 | 55 | | 2005 | 5 | 34 | 39 | | 2006 | 13 | 46 | 59 | | 2007 | 7 | 31 | 38 | | 2008 | 9 | 37 | 46 | | 2009 | 12 | 43 | 55 | | 2010 | 10 | 34 | 44 | | 2011 | 17 | 28 | 45 | | 2012 | 17 | 29 | 46 | | 2013 | 14 | 24 | 38 | | 2014 | 10 | 22 | 32 | | 2015 | 13 | 28 | 41 | | 2016 | 11 | 25 | 36 | | 2017 | 14 | 15 | 29 | | 2018 | 7 | 32 | 39 | | 2019 | 15 | 12 | 27 | | 2020 | 10 | 26 | 36 | | 2021 | 10 | 15 | 25 | | 2022 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Greenland P, Polonsky TS. 40 Years of Research on Coronary Artery Calcium and Still No Convincing Clinical Trials? JACC Cardiovasc Imaging. 2022 05; 15(5):856-858.
-
Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, Moghaddam B, Ahuja V, Ali SA, Allez M, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Kotze PG, Koutroubakis IE, Lakatos PL, Lindsay JO, Magro F, Mantzaris GJ, Ng SC, O'Morain C, Panés J, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Siegmund B, Steinwurz F, Tysk C, Vavricka S, Verstraete SG, Brezin AP, Haemel AK, Dignass A, Sands BE, Danese S, Peyrin-Biroulet L. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet Gastroenterol Hepatol. 2022 03; 7(3):254-261.
-
Stavas J, Gerber D, Coca SG, Silva AL, Johns A, Jain D, Bertram T, Díaz-González de Ferris M, Bakris G. Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design. Am J Nephrol. 2022; 53(1):50-58.
-
Gordon KB, Lebwohl M, Papp KA, Bachelez H, Wu JJ, Langley RG, Blauvelt A, Kaplan B, Shah M, Zhao Y, Sinvhal R, Reich K. Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis. Br J Dermatol. 2022 03; 186(3):466-475.
-
Herman AL, Sheth KN, Williams OA, Johnston KC, Prabhakaran S, de Havenon A. Self-Reported Race as a Social Determinant of Stroke Risk in Observational Versus Clinical Trial Datasets. J Stroke Cerebrovasc Dis. 2022 Feb; 31(2):106219.
-
Karas S, Etheridge AS, Nickerson DA, Cox NJ, Mohlke KL, Cecchin E, Toffoli G, Mathijssen RHJ, Forrest A, Bies RR, Innocenti F. Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients. Br J Cancer. 2022 03; 126(4):640-651.
-
Kinoshita S, Colby KA, Kruse FE. A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal Dystrophy. Cornea. 2021 Oct 01; 40(10):1225-1228.
-
German CA, Elfassy T, Singleton MJ, Rodriguez CJ, Ambrosius WT, Yeboah J. Trajectories of Blood Pressure Control a Year After Randomization and Incident Cardiovascular Outcomes in SPRINT. Am J Hypertens. 2021 09 22; 34(9):973-980.
-
Yuan J, Khilnani A, Brody J, Andtbacka RHI, Hu-Lieskovan S, Luke JJ, Diab A, Marabelle A, Snyder A, Cao ZA, Hodi FS. Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition. Eur J Cancer. 2021 11; 157:493-510.
-
de Havenon A, Anadani M, Prabhakaran S, Wong KH, Yaghi S, Rost N. Increased Blood Pressure Variability and the Risk of Probable Dementia or Mild Cognitive Impairment: A Post Hoc Analysis of the SPRINT MIND Trial. J Am Heart Assoc. 2021 09 21; 10(18):e022206.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|